Eight types of sartan high blood pressure medicine have been recalled after being found to contain a potential carcinogen, Taiwan Food and Drug Administration (FDA) said on Monday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
Foster carer, sister indicted in fatal child abuse case
04/18/2024 01:54 PM - Society
Taiwan headline news
04/18/2024 12:47 PM - Business
U.S. dollar down in Taipei midday trading
04/18/2024 12:40 PM - Society
Heavy rain advisory issued for northern Taiwan
04/18/2024 12:29 PM - Business
Taiwan shares open lower
04/18/2024 10:09 AM